Finetalks for Bayer

A more human format for expert medical conversations

For Finetalks, a Bayer initiative created for healthcare professionals, HOW handled the production, post-production and final delivery of a studio-based conversation format.

Our role was to help shape a more natural and approachable audiovisual tone, while fully respecting the scientific rigor of the content. The medical framework, questions and final content approval were defined by Bayer and subject to regulatory review.

Rather than relying on a conventional formal setup, we worked to create a more fluid and human conversation format — one that felt closer, clearer and more engaging for a professional audience.

The result was a piece that balanced credibility, clarity and warmth, helping expert dialogue feel more accessible without losing seriousness.

Disclaimer

This project was developed for a professional healthcare audience. The medical content, questions and scientific messaging were defined and approved by Bayer in accordance with the corresponding regulatory process. The referenced material may be publicly accessible, but it is intended for healthcare professionals.

Anterior
Anterior

OLYMPUS OM-D

Siguiente
Siguiente

Condis franchises